BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Prognosis
4000 results:

  • 1. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
    PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
    Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
    BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
    Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
    J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. IL-6 significantly correlated with the prognosis in low-grade glioma and the mediating effect of immune microenvironment.
    Yang SD; Chen MZ; Yang DF; Hu SB; Zheng DD
    Medicine (Baltimore); 2024 May; 103(19):e38091. PubMed ID: 38728467
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Glioma.
    Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
    Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
    Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
    J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
    Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
    BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic Implications of Small Cell Lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Two-headed UNetEfficientNets for parallel execution of segmentation and classification of brain tumors: incorporating postprocessing techniques with connected component labelling.
    Rai HM; Yoo J; Dashkevych S
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):220. PubMed ID: 38684578
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].
    Hua D; Zhou XX; Wang Q; Sun CY; Shi CJ; Luo WJ; Jiang ZD; Yu SZ
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):430-438. PubMed ID: 38678322
    [No Abstract]    [Full Text] [Related]  

  • 14. Survival prediction in patients with gynecological cancer irradiated for brain metastases.
    Os SS; Skipar K; Skovlund E; Hompland I; Hellebust TP; Guren MG; Lindemann K; Nakken ES
    Acta Oncol; 2024 Apr; 63():206-212. PubMed ID: 38647023
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
    Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
    CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
    Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
    Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Analysis of the sodium pump subunit ATP1A3 in glioma patients: Potential value in prognostic prediction and immunotherapy.
    Lan YL; Zou S; Qin B; Zhu X
    Int Immunopharmacol; 2024 May; 133():112045. PubMed ID: 38615384
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The emerging role of fatty acid binding protein 7 (FABP7) in cancers.
    George Warren W; Osborn M; Yates A; O'Sullivan SE
    Drug Discov Today; 2024 May; 29(5):103980. PubMed ID: 38614160
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Gene Expression Patterns Associated with Survival in Glioblastoma.
    Morrison C; Weterings E; Gravbrot N; Hammer M; Weinand M; Sanan A; Pandey R; Mahadevan D; Stea B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612480
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial.
    Mao J; Ni J; Chu L; Chu X; Xu D; Yang X; Zhu Z
    Radiat Oncol; 2024 Apr; 19(1):47. PubMed ID: 38610031
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 200.